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Abstract
The gap in Kenya between need and treatment for mental disorders is wide, and private providers are increasingly offering
services, funded in part by private health insurance (PHI). Chiromo, a 30-bed psychiatric hospital in Nairobi, forms part of
one of the largest private psychiatric providers in East Africa. The study evaluated the effects of insurance on service use
and charge, questioning implications on access to care. Data derive from invoices for 455 sequential patients, including 12-
month follow-up. Multi-linear and binary logistic regressions explored the effect of PHI on readmission, cumulative length of
stay, and treatment charge. Patients were 66.4% male with a mean age of 36.8 years. Half were employed in the formal
sector. 70% were admitted involuntarily. Diagnoses were: substance use disorder 31.6%; serious mental disorder 49.5%;
common mental disorder 7%; comorbid 7%; other 4.9%. In addition to daily psychiatric consultations, two-thirds received
individual counselling or group therapy; half received lab tests or scans; and 16.2% received ECT. Most took a psychiatric
medicine. Half of those on antipsychotics were given only brands. Insurance paid in full for 28.8% of patients. Mean length
of stay was 11.8 days and, in 12 months, 16.7 days (median 10.6). 22.2% were readmitted within 12 months. Patients with
PHI stayed 36% longer than those paying out-of-pocket and had 2.5 times higher odds of readmission. Mean annual charge
per patient was Int$ 4,262 (median Int$ 2,821). Insurers were charged 71% more than those paying out-of-pocket - driven by
higher fees and longer stays. Chiromo delivers acute psychiatric care each year to approximately 450 people, to quality
and human rights standards higher than its public counterpart, but at considerably higher cost. With more efficient delivery
and wider insurance coverage, Chiromo might expand from its occupancy of 56.6% to reach a larger population in need.
Citation: de Menil VP, Knapp M, McDaid D, Njenga FG (2014) Service Use, Charge, and Access to Mental Healthcare in a Private Kenyan Inpatient Setting: The
Effects of Insurance. PLoS ONE 9(3): e90297. doi:10.1371/journal.pone.0090297
Editor: Una Macleod, Supportive care, Early DIagnosis and Advanced disease (SEDA) research group, United Kingdom
Received June 17, 2013; Accepted February 3, 2014; Published March 20, 2014
Copyright:  2014 de Menil et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The study is self-funded as part of research towards the completion of a PhD at the London School of Economics. Victoria Pattison de Menil designed
the study, collected the data, analysed it and wrote it up.
Competing Interests: Dr. Frank Njenga is a member of the Board of Directors of Chiromo Lane Medical Center and chairs the AAR health management
organization in Kenya. He also heads the National Campaign Against Drug Abuse (NACADA), the government authority on the prevention and treatment of
substance use disorders. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: v.p.de-menil@lse.ac.uk
Introduction
Government allocations account for only one third (30.0%) of
Kenyan health spending. Two-thirds of the Int$78 per capita
health expenditure [1] are split between international donors
(29.4%) and out-of-pocket payments (36.7%), with the remainder
from private companies [2]. Out-of-pocket payments (OPP) go
predominantly (76.3%) to hospitals, including private for-profit
hospitals, which account for 14.9% of this expenditure (ibid). OPP
are associated with catastrophic loss in low-income countries [3],
so policy makers have been vying to create social health insurance
[4,5].
In 2004, Kenya’s parliament passed a promising bill to create a
National Social Health Insurance Fund, which would fund both
outpatient and inpatient care for all Kenyans using a sliding scale
of contributions [4]. Disappointingly, the bill was not signed into
law, because of concern over the feasibility of its financing. Now,
the only operational social insurance is the National Hospital
Insurance Fund (NHIF), which is under investigation by Kenya’s
Ethics and Anti-Corruption Commission, and which allocates only
22% of funds towards benefits [4]. NHIF pays a flat-fee of Ksh 800
(Int$ 20.8) for inpatient stays and enrolment is mandatory for all
formal sector employees; but currently it covers only 5.5% of the
population [2].
In this context of barriers to national insurance, private health
insurance (PHI) remains one alternative to user fees for financing
healthcare, among those who can afford it. In Kenya, PHI is used
by 2% of the population and accounts for 4% of total health
expenditure [2,6]. Critics of PHI argue that it benefits only the
rich and leads to spiralling use and costs of services, while
proponents suggest that it provides financial protection, increases
early access to services, and mitigates problems of wait-time and
quality [7]. The debate remains largely theoretical in low-income
settings in the absence of evidence. A systematic review of
randomised controlled trials and observational studies about the
impact of health insurance in Africa and Asia found only one study
of PHI, from Asia [8].
Despite broad interest in private healthcare in Africa [9], there
is also a noted gap in the literature on private mental healthcare
[10,11] with some exception for private-public partnerships [12].
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In Kenya, mental health is among the lowest priorities of the
public health system, accounting for less than 1% of the health
budget – on par with the mean of 0.5% across low-income
countries [13]. Public psychiatric inpatient care for a population of
38 million is relegated to one 600-bed psychiatric hospital,
Mathari, seven provincial and six district hospitals with psychiatric
wards of approximately 20 beds each.
Private providers are increasingly offering mental health services
in Kenya, particularly for substance disorders. Kenya has 80
practicing psychiatrists and 44% of them work in private practice
[14]. Kenya’s national authority on drug and alcohol abuse
(NACADA) lists 35 registered rehabilitation centres: only three are
public, and 80% were founded since 2000 [15]. While no local
studies have offered an explanation for this growth, evidence from
rapidly developing countries in Asia suggests that, on the demand-
side, service users prefer non-state provision because they perceive
the non-state sector as having more flexible access, shorter waiting
times, greater confidentiality, and greater sensitivity to their needs
[16]. Anecdotally, psychiatric patients in Kenya cite greater
availability and wider choice of medication as an incentive for
private care. On the supply-side, Kenya’s Mental Health Act of
1989 prohibits discrimination against mental illness by insurance
companies. In recent years, most insurance companies have
changed their policies to obey this law. AAR was a leader in that
change, under the chairmanship of Frank Njenga, co-author on
this paper. In addition, substantial growth of the Kenyan economy
in recent years is likely to expand the number of citizens who are
in a position to obtain private health insurance [17,18].
This paper looks in detail at one private facility, the Chiromo
Lane Medical Centre. Founded in 1996, Chiromo offers acute
private psychiatric care in a small (30-bed) hospital with
comfortable accommodation, aspiring to ‘‘recovery in dignity.’’
Located in a former private home in the wealthy Westlands
neighbourhood of Nairobi, it maintains the structure and feel of a
home – open doors, small rooms and a garden. Chiromo is part of
a five-facility hospital group, consisting of two other acute
psychiatric hospitals, a rehabilitation centre and a half-way house
for substance abusers. The founding staff are a social worker and
three psychiatrists trained at the Maudsley hospital in London,
UK, prior to establishment of psychiatric training in Kenya (1971).
With a joint capacity of 102 beds, the Chiromo Hospital Group is
one of the largest providers of private psychiatric services in Kenya
and East Africa.
The purpose of this paper is to evaluate the effects of PHI on 1)
the quantity of psychiatric services provided; and 2) total charge,
and to explore the implications on access to care.
Methods
Service utilisation and charge were analysed from all hospital
invoices between 28 March 2011 and 27 March 2012. Twelve-
month follow-up data was obtained on readmissions. Medication
use was recorded for a sub-set of the first 100 unique discharges in
the same period. These data were complemented by direct
observation of clinical practice by the first author over two weeks
in June 2012.
In order to explore variations in amount and components of
care, linear and binary logistic regressions were run in SPSS 19 on
four dependent variables: readmission, annual length of stay,
charge per day, and annual charge. Covariates were age, sex,
diagnosis, insurance, and whether the patient was employed.
In costing, the unit bed fee was held constant using March 2012
rates. Int$ were converted using the International Monetary Fund
rate of 38.4 Ksh to 1 Int$. Doctors’ fees were imputed for one third
of discharges using mean values according to doctor and payment
type.
The research methodology was approved by the Ethics and
Research Committee of Kenyatta National Hospital and Univer-
sity of Nairobi (P450/10/2011). Patient consent for review of
medical records was waived by the review committee.
Results
1. Patients
455 unique patients were seen in 12 months.
Demographics. Two thirds were male with a mean age of
36.3 years (range 14–82) and nationally representative religions
(table 1) [19]. Three-quarters provided addresses in Nairobi; and
during the site visit, 20% were foreign, from the Democratic
Republic of Congo, Somalia and South Sudan. Half were
employed in the formal sector, and a quarter were students.
Diagnosis. One third had a primary diagnosis of substance
use disorder, and half had a serious mental disorder (SMD) (e.g.
schizophrenia, bipolar, psychosis). Only 7% had a common
mental disorder (CMD) (e.g. depression or anxiety); a further 7%
had comorbid psychiatric diagnoses.
Insurance. A quarter (28.5%, n= 130) had care paid in full
by an insurance provider (n = 72) or employer (n = 58). Twenty-
one insurers and 29 companies provided coverage, in all cases
without co-payment. There was no association between diagnosis
and being insured (chi square p= 0.54). The association between
being insured and being employed was not significant at the 0.05
level (chi-square, p = 0.08). In addition, NHIF partially reimbursed
29% of patients (n = 133) with Int$ 20/day (Ksh 800). A third
(36.8%) of those receiving NHIF paid for the rest of their care out
of pocket.
An interview with one insurer indicated an inpatient coverage
ceiling of Int$ 6,600 (Ksh 250,000), which had increased 2.5 fold
in the past decade from Int$ 2,600 (Ksh 100,000). Suicidality and
substance use disorders were excluded from all coverage; and pre-
existing conditions were excluded from individual, as opposed to
corporate, coverage. The pre-existing condition policy recently
changed, however, to introduce coverage sub-limits for people
with chronic disease.
2. Service Use
Patients were admitted by their psychiatrist. Fourteen psychi-
atrists admitted patients in 12 months; however 87% of patients
were admitted by only four doctors, three of them hospital
directors.
Psychological therapies. In addition to daily consultations
of approximately 15 minutes with a psychiatrist, two-thirds of
patients received either individual counselling (60.2%) or group
therapy (36.9%). Also, all patients were invited to participate in
daily half-hour community meetings, attended by nursing and
counselling staff, which were occasions for voicing ‘‘compliments
and complaints’’ about care. Counselling was given by one of four
full-time university educated counsellors. Patients receiving
individual counselling averaged 1.2 sessions per week, each lasting
up to an hour. Group therapy existed in various forms, including
psycho-education, art therapy and (rarely) family therapy. Patients
receiving group therapy averaged 1.4 sessions a week.
Lab tests and scans. Over half of all patients received a lab
test or a scan. The most common lab tests were blood tests, liver
and thyroid functions, urinalysis, and diagnostics for infectious
disease (e.g. HIV, malaria). Tests were also conducted to verify
blood levels of medications, such as lithium. Scans included x-rays,
electroencephalograms (EEG) for epilepsy, computerised tomog-
Insurance Effects on Psychiatry in Kenya
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Table 1. Population Characteristics & Services Used.
Demographics:
Male 66.4%
Age 36.3 (sd 13.6)
Nairobi address 77.7%
Religion:
Christian 90.6%
Muslim 8.0%
Hindu or undeclared 1.4%
Occupation:
Formal sector employment 50.6%
Students 26.7%
Unemployed or retired 13.5%
House-wives 4.6%
Farmer or informally employed 4.6%
Earning income 55.2%
Diagnosis:
Alcohol disorder 21.2%
Drug disorder 10.4%
Schizophrenia or non-affective psychosis 38.4%
Bipolar disorder 11.4%
Schizo-affective disorder 2.7%
Depression or anxiety 7.0%
Comorbid psychiatric disorders 7.0%
Financing:
Insurance (100% of fees) 15.8%
Employer (100% of fees) 12.7%
Out-of-pocket 71.5%
NHIF (Int$20 co-pay) 29.0%
Services:
Individual counseling 60.2%
Group therapy 36.9%
Lab tests 55.6%
Scan 9.9%
ECT 16.2%
Psychiatric medicine 91.0%
Medicines
Antipsychotic 81.0%
Sedatives 70.0%
Antidepressants 21.0%
Anticonvulsants 17.0%
Alcohol or drug medicine 9.0%
Lithium 5.0%
Methylphenidate 2.0%
Received only branded antipsychotics 50.6%
Received an injection 76.7%
Length of stay mean median sd
Length of stay per hospitalization 11.8 days 9.0 days 10.0
Cumulative length of stay in 12 months 16.7 days 10.6 days 18.5
Involuntary admissions 70.0%
doi:10.1371/journal.pone.0090297.t001
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raphy (CT) head scans, magnetic resonance imaging (MRIs) and
ultrasounds.
Electro-convulsive therapy (ECT). Sixteen percent (n = 74)
received modified ECT, averaging 4.9 sessions (max12, s.d. 1.8).
Medicines. Nearly all (91%) patients were prescribed a
psychiatric medicine (mean 3.3 medicines). The most commonly
prescribed medicines were: antipsychotics 81%; sedatives 70%;
antidepressants 21%; and anticonvulsants 17%. A wide range of
medicines was available, including six antidepressants (3 selective
serotonin reuptake inhibitors, 2 seratonin-neuropinephrine reup-
take inhibitors and an adrenergic receptor antagonist) and nine
antipsychotics (4 typical, 5 atypical).
In general, doctors prescribed branded drugs, and the
pharmacist was required to fill the prescription as written. Six of
the nine antipsychotics and five of six antidepressants were
prescribed in only brand form. Among patients taking antipsy-
chotics, half (50.6%, n= 42) were given only branded medicines.
For olanzapine, given in brand and generic forms, the brand cost
15 times the generic. Reasons for preferring brands included: 1)
greater quality assurance; 2) preferable means of administration
(e.g. soluble drops for olanzapine); 3) patient preference.
At the site visit, 70% (n= 14) of patients were admitted
involuntarily, and therefore had limited treatment choice,
including medication. (Kenya’s mental health law requires
authorization from one doctor and one family member for
involuntary admission.) Some said they received injectable
medicines more than they would like. Indeed, three-quarters
(76.7%) received an injection. Doctors and nurses preferred
injection because it circumvents problems of adherence. In the
words of one staff: ‘‘If you refuse medicines, what help are you getting? …
You are wasting a whole day that is payable.’’
3. Length of Stay, Readmission and Charge
Length of stay and readmission. Mean length of stay
(LOS) was 11.8 days (max 93, sd 10.0). One quarter (22.2%) of
patients were readmitted within 12 months (mean 1.4 readmis-
sions). Mean cumulative stay in 12 months was 16.7 days (median
10.6, max 153, sd 18.5).
Charges and components of care. Chiromo charged fee-
for-service with lower fees for patients paying out-of-pocket.
Patients paid a flat ‘‘bed fee’’ per night for accommodation and
hired staff, which amounted to nearly half (45.8%) the total charge
(table 2). A minority (11.8%) had private rooms, while the
remainder stayed in shared rooms for 3–4 people. Those paying
out-of-pocket paid an upfront deposit of Int$ 911 (Ksh 35,000) to
cover approximately one week of ‘‘bed fees.’’
The second leading component of charges was psychiatric
consultations, which represented one third (30.2%) of fees.
Medications were the third highest expense, amounting to
10.0% of the invoice. The lowest-cost intervention was non-
medical psychological therapies at only 1.6% of charges.
Mean charge per patient day in the general ward was Int$ 266
(Ksh 10,218). The distribution of total annual charge was skewed
with mean Int$ 4,262 (Ksh 163,648) and median Int$ 2,821 (Ksh
108,333).
Regression results (table 3) indicate that having PHI was a
significant predictor of readmission, cumulative length of stay and
charge per day. Patients with PHI were 2.5 times more likely to be
readmitted than those paying out-of-pocket, controlling for
diagnosis, age, sex, and employment. They also stayed 36%
longer (95% CI 13%–60%), and paid on average 25% more per
day (95% CI 17%–34%) than those paying out-of-pocket. The
combination of longer stays and higher pricing led the overall
annual charge to be on average 71% higher (95% CI 35%–117%)
for those with PHI than those paying out-of-pocket.
Age and sex had no effect on service use outcomes (length of
stay, readmission, charge); however their effects may have been
mediated by diagnosis and employment. Being employed was
associated with lower rates of readmission and shorter lengths of
stay; while having a severe mental disorder was associated with a
slightly higher charge per day. Running the regression for
readmission without employment and with a larger sample
(n = 301) showed that severe mental disorder was significantly
associated with readmission. It seems that the effect of having a
severe mental disorder is mediated by a greater likelihood of not
being in paid employment, which itself appears to shorten the
overall hospital stay.
Discussion
The salient finding of this study is the positive association
between PHI and quantity of care. In the absence of data on
health outcomes, it cannot be rigorously determined whether
additional days of hospitalization and readmission indicate moral
hazard of insurance or greater access to needed treatments;
however the literature provides some benchmarking of quantity of
care against which to begin to assess the quality of care in this
setting.
Literature from other parts of the world on the effects of
insurance on service use for chronic disease suggest that insurance
may be associated with more care. On the side of quantity, a small
study from Argentina found the odds of anti-depressant use were
7.2 times higher among the insured than the uninsured [20]. A
study examining insurance effects among 3,824 participants with
common mental disorders in Santiago, Chile, found that half were
privately insured, and they had 2.7 times higher odds of receiving
a mental health consultation than those publicly insured, adjusting
for the more severe symptoms found among the publicly insured
[21]. Health insurance was therefore associated with more
coverage in a context of low overall coverage (20% of those with
disorders received any consultation), but also with increased
inequality. Health outcomes for those on insurance may also be
better, as suggested by findings from a large-scale study of a
general population in China where having health insurance (of
unspecified type) was associated with lower severity of depressive
symptoms [22].
In a higher-income context, the inverse relationship was found
in relation to quantity of care and private insurance. A study from
Israel observed that when insurance was associated with fee-for-
service (ie a fee per inpatient day), it resulted in lower length of stay
for mental disorders than in public healthcare, where provider
payments were made based on an annual global budget [23]. The
modality of provider payments may be as important as insurance
in determining the quantity of care.
In the African context, Chiromo has considerably shorter stays
than most psychiatric hospitals, suggesting there is not an evident
over-consumption of care. A general teaching hospital in
Johannesburg approximates Chiromo with a mean psychiatric
LOS of 15.4 days [24], but a readmission rate of only 7.5%,
suggesting better continuity of care after discharge [25]. A public
general hospital in South Africa, found a mean LOS for psychotic
men of 43.9 days (sd 39.4) [26]. And a general public teaching
hospital in Nigeria had a mean psychiatric LOS of 28.7 days
(n = 371) [27].
In relation to components of care, Chiromo’s ECT rate is high
by global standards, but lower than among inpatient psychiatric
populations elsewhere in Africa: it ranges from 21–28% in
Insurance Effects on Psychiatry in Kenya
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Malawi, Nigeria and South Africa [28]. The mean of 5 sessions
approximates the 6 session dose recommended by the UK’s
National Institute for Health and Care Excellence (NICE) [29].
At 57.6%, occupancy rates were low at the time of study. One
reason for keeping beds empty is that staffing capacity was not on
par with infrastructural capacity, so that while the hospital could
physically accommodate more patients, it could not do so to
desired levels of quality. Another potential reason for low
occupancy was the financial barrier to treatment.
With a per-capita GDP of Int$ 1,015 (Ksh 38,970) [30],
treatment at Chiromo lies well beyond the reach of most Kenyans,
making charge the main barrier to access. Indeed, Chiromo’s
occupational profile departs markedly from the national norm,
with 50.6% of patients in formal employment, as compared to an
average of only 9% of working age people (14% of those
employed) [31]. By comparison, the World Health Organization’s
method for Choosing Programmes that are Cost-Effective (WHO
CHOICE) estimates the ‘‘hotel cost’’ (personnel, capital, food) of
an inpatient bed/day in a public, urban hospital in Kenya at Int$
14.49 (Ksh 505) [32]. A comparable figure at Chiromo is the daily
‘‘bed fee’’ of Int $119 (Ksh 4500), considerably above the public
sector estimate. Anecdotally, the lowest-income patients observed
during the site-visit (eg someone employed lifting cement) were
among those with employer-based insurance. Increasing insurance
therefore may be a means of providing access to care from a
broader population base.
If Chiromo patients have better outcomes than those in the
public sector, the additional cost of care could be justified from an
economic perspective. There are insufficient outcome data to
rigorously compare; however some process indicators provide
Table 2. Component and Aggregate Charges.
Mean Component Charge Int$ Ksh % total charge
‘‘Bed fee’’ (hotel fee) - out-of-pocket 117 4,500 45.8%
‘‘Bed fee’’ - insured 130 5,000
Psychiatrist 78–104 3,000–4,000 30.2%
Medication per day 32 1,220 10.0%
E.C.T 299 11,500 7.9%
Labs & scans 151 5,800 3.6%
MRI 234 9,000
x-ray 39 1,500
Talk therapy 1.6%
art therapy 5 200
psycho-education groups 13 500
individual counselling 26 1,000
Other (eg external consults) 0.9%
Total 100.0%
Aggregate Charge Int$ Ksh S.D.
Mean charge per day 266 10,227 2,625 (Ksh)
Mean charge per year 4,276 164,215 167,927 (Ksh)
Median charge per year 2,821 108,326 71,622 (Ksh)
doi:10.1371/journal.pone.0090297.t002
Table 3. Predictors of readmission, length of stay and charge (regression analyses).
Readmission (yes/no) (n =244) annual LOS (ln) (n =244) Charge/day (ln) (n = 242) Total charge (ln) (n = 242)
Predictor Exp(B) S.E. Sig. B S.E. Sig. B S.E. Sig. B S.E. Sig.
Age 0.99 0.02 0.11 0.01 0.01 0.11 0.00 0.00 0.73 0.01 0.00 0.07
Sex 1.14 0.46 0.67 20.05 0.12 0.67 20.05 0.03 0.13 20.10 0.12 0.41
Payer 2.47 0.44 0.01 0.31 0.12 0.01 0.22 0.04 ,.01 0.54 0.12 ,0.01
Diagnosis
- SMD 1.98 0.52 0.70 0.14 0.12 0.70 0.07 0.03 0.04 0.21 0.12 0.08
- CMD & other1.63 0.70 0.24 0.06 0.16 0.24 0.02 0.05 0.62 0.09 0.16 0.56
Employed 2.22 0.49 0.06 20.21 0.11 0.06 20.03 0.03 0.37 20.24 0.11 0.03
Log likelihood
or R2
LL = 156 R2 = 0.04 R2 = 0.15 R2 = 0.10
Reference group for diagnosis is substance use disorder.
doi:10.1371/journal.pone.0090297.t003
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insight into the relative quality of care. The diagnostic profile at
Chiromo mirrors that in Kenya’s public psychiatric hospital,
Mathari, where 34.4% have a substance use disorder; and 51.0%
have schizophrenia or psychosis [33]. Chiromo’s readmission rate
of 22.2% is also in keeping with the that of 24.6% found in
Mathari hospital [33]; however comparison on readmission is
limited by the absence of published data on length of stay at
Mathari.
A more meaningful comparison may be along the lines of
human rights. In February 2011, CNN released a scathing
documentary about Mathari [34] showing a dead body beside a
live patient in an isolation cell. In response, the Kenya National
Commission on Human Rights audited public mental healthcare,
noting ‘‘systemic neglect’’ [35]. The Commission inspected three
public psychiatric inpatient units, finding staff-to-patient ratios of
1:80, and occupancy rates from a low of 105% to a high of 200%.
Hygiene was poor, and hospitals lacked basic resources and
equipment, like a functioning ECT machine. By comparison,
Chiromo has a qualified nurse-to-patient ratio of 1:20, hygiene is
good, the pharmacy is stocked without shortage, and the ECT
functions.
Conclusion
Chiromo delivers acute psychiatric care each year to approx-
imately 450 people, to quality and human rights standards higher
than its public counterpart, but at considerably higher cost. If
there were more efficient (lower-cost) ways of delivering care,
Chiromo might expand its services and increase its occupancy.
Means of lowering inpatient costs include: 1) using more generics;
2) shifting the mix in staff to reduce reliance on psychiatrists; and
3) reducing readmissions, possibly through developing more
outpatient psychosocial interventions and intermediary care.
Chiromo moved in this direction with the creation in 2012 of a
half-way house for substance abuse; the same model could be
applied for non-substance related psychiatric disorders. Incentives
for cost-cutting could be built into insurance, for example by
mandating the use of generics.
Our findings are limited by the absence of clinical outcome
measures and of comparable data from the public sector.
Comparison is also challenged by a lack of indicator of illness
severity. Furthermore, generalizations on the overall quality of
private versus public care cannot be made on the basis of this
single case. Indeed, the Chiromo model is not currently
generalizable, because its concentration of qualified professionals
would be unsustainable at scale in this low-income setting.
Nonetheless, this study is notable as a first analysis of insurance
effects on mental healthcare in Africa, and provides a useful
benchmark of private inpatient practice against which to measure
alternatives and future change.
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